Central pontine myelinolysis screening: Difference between revisions
(Created page with "__NOTOC__ {{Central pontine myelinolysis}} {{CMG}}; {{AE}} {{MMJ}} ==Overview== ==Screening== There is insufficient evidence to recommend routine screening for [disease/mal...") |
(No difference)
|
Revision as of 08:09, 2 November 2019
Central pontine myelinolysis Microchapters |
Differentiating Central pontine myelinolysis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Central pontine myelinolysis screening On the Web |
American Roentgen Ray Society Images of Central pontine myelinolysis screening |
Risk calculators and risk factors for Central pontine myelinolysis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
Screening
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]